Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seventeen research firms that are currently covering the stock, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $38.1786.
A number of analysts have recently issued reports on the company. Wall Street Zen lowered Bath & Body Works from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. Barclays lowered their price objective on Bath & Body Works from $32.00 to $28.00 and set an “equal weight” rating for the company in a research note on Monday, October 20th. Raymond James Financial reaffirmed a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday. Jefferies Financial Group decreased their price target on shares of Bath & Body Works from $32.00 to $28.50 and set a “hold” rating for the company in a research report on Monday, October 13th. Finally, Wells Fargo & Company dropped their price target on shares of Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating for the company in a research note on Monday, October 27th.
Get Our Latest Stock Analysis on Bath & Body Works
Bath & Body Works Trading Down 0.1%
Bath & Body Works (NYSE:BBWI – Get Free Report) last released its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The firm had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.55 billion. During the same quarter in the previous year, the firm posted $0.37 EPS. The firm’s quarterly revenue was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, research analysts expect that Bath & Body Works will post 3.3 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, December 5th. Stockholders of record on Friday, November 21st will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.6%. The ex-dividend date is Friday, November 21st. Bath & Body Works’s dividend payout ratio is 23.74%.
Hedge Funds Weigh In On Bath & Body Works
A number of hedge funds have recently bought and sold shares of BBWI. First Horizon Corp acquired a new stake in Bath & Body Works during the third quarter valued at approximately $29,000. Stonehage Fleming Financial Services Holdings Ltd bought a new stake in shares of Bath & Body Works in the 2nd quarter valued at approximately $33,000. SVB Wealth LLC acquired a new stake in shares of Bath & Body Works during the 1st quarter valued at approximately $35,000. Geneos Wealth Management Inc. raised its position in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares in the last quarter. Finally, Parallel Advisors LLC lifted its stake in Bath & Body Works by 63.3% during the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after purchasing an additional 481 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.
About Bath & Body Works
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Further Reading
- Five stocks we like better than Bath & Body Works
- Conference Calls and Individual Investors
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
- How to Invest in Insurance Companies: A Guide
- 3 Under-the-Radar AI Stocks to Buy on the Dip
- Ride Out The Recession With These Dividend Kings
- Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
